Every day, our Money Morning experts serve up the best stocks to invest in now for readers who want to build a strong portfolio. Each week we collect the latest recommendations in one roundup, in case you missed any.
Last week, Money Morning Defense & Tech Specialist Michael A. Robinson picked a healthcare exchange-traded fund (ETF) set to gain handsomely from M&A activity.
Our Resource Specialist Peter Krauth discussed two opportunities to profit from the ongoing currency turmoil in Europe.
Chief Investment Strategist Keith Fitz-Gerald offered two stocks and an ETF that will benefit from China's burgeoning economic landscape.
And there are two more picks ahead. You can find all of them here in our newest compilation of the best stocks to invest in now.
Money Morning's Recap of the Best Stocks to Invest in Now
Wall Street pundits have declared healthcare mergers and acquisitions "dead." Their skepticism arose in October after AbbVie Inc. (NYSE: ABBV) got cold feet and backed out of its $54 billion merger with Shire Plc. (Nasdaq ADR: SHPG). But Money Morning Defense & Tech Specialist Michael A. Robinson knows healthcare mergers are actually booming. In fact, he found that global healthcare M&A has soared 124% to $35.1 billion so far this year. That marks the best start for the sector since 2009. A report by Thomson Reuters found that M&A among healthcare companies is the third highest by sector behind telecommunications and finance firms. That's why Robinson told readers about a pharmaceutical ETF holding many companies likely to grow through M&A over the next two years...
China's economy grew more than 7% last year, beating 2.4% growth in the United States, according to Forbes. China was responsible for almost 12% of all global exports in 2013 and may hit 15% by 2016. Money Morning Chief Investment Strategist Keith Fitz-Gerald says we're seeing a huge shift in both global power and capital, opening up a salvo of profit opportunities for investors who get in early. The country is changing in both demographics and technology - two of Fitz-Gerald's Unstoppable Trends guaranteed to offer big gains. Check out his three picks here, including a robotics company, tech titan, and ETF...
Natural gas consumption has skyrocketed over the last 60 years. Natural gas' share of total energy consumption increased from 17% in 1950 to more than 50% last year. It constitutes nearly one-quarter of the world's energy supply. And liquefied natural gas (LNG) is the fastest-growing component of the natural gas market. The Energy Information Administration reported the LNG trade has been growing at a 7% annual rate over the last 10 years. That's why one of our favorite energy picks is a play on LNG. Money Morning Global Energy Strategist Dr. Kent Moors first told investors about this stock in 2011, and it's up 671% since...
There's one drug market that expects to see consumer spending quadruple over the next five years. The sector is known as "high-margin specialty drugs" - expensive medications that treat complex, chronic, and debilitating illnesses. One of these drugs, Soliris, costs patients about $410,000 per year. As you can guess, these specialty drugs have fueled huge gains in pharmaceutical stocks. Soliris-owner Alexion Pharmaceuticals Inc. (Nasdaq: ALXN) is up more than 625% since 2010. The best stock in this sector has a drug that will benefit from a 200% spending increase in 2015 and 2016...
Bonus Content: The small-cap sector has been crushing the broader market recently. The Russell 2000 - the broadest measurement for small-cap stocks - is up 18.4% since October. Money MorningSmall-Cap Investing Specialist Sid Riggs just outlined how to invest in the best small-cap companies. Here's how you can get in on the booming sector...